[ad_1]
[앵커]
The COVID-19 antibody treatment from US biotech company Regeneron has been approved for emergency use by the US Food and Drug Administration. The drug was used in the treatment of Corona 19 by President Trump of the United States of America, and at the time, President Trump praised its immediate improvement. Reporter Chae Moon-seok in the press. The United States Food and Drug Administration (FDA) has approved the emergency use of the antibody treatment that Regeneron is developing. This drug can be used to treat COVID-19 patients with mild to moderate symptoms older than 12 years. High-risk patients over the age of 65 are also eligible. This drug tests for antibodies in the blood for a cure for Corona 19, selects only antibodies that can neutralize the virus, and then turns it into a treatment. It is a one-time treatment that is given through an IV. In clinical trials, high-risk patients who received the drug were less likely to be hospitalized or go to the emergency room for corona symptoms within 28 days, compared to the control group who received the drug, he said. the FDA. The policy is to continue to evaluate the safety and effectiveness of this drug. The drug, along with Ramdesivir, was used last month as a cure for President Trump when he contracted Corona 19, which President Trump praised for an immediate improvement. Regeneron has already announced plans to produce 80,000 servings by the end of this month and increase production to 300,000 servings by the end of January next year. In the midst of this, the number of cumulative corona 19 cases in the United States has already exceeded 12 million. In just six days, it increased a million people. As the situation worsened, the state of California entered an overnight curfew and New York City issued a school closure order for 1.1 million students. Before Thanksgiving on the 26th of this week, measures are being tightened to curb the spread of Corona 19. This is Moonseok Chae, YTN.
